AbbVie (ABBV) EBT Margin (2012 - 2026)

AbbVie has disclosed EBT Margin across 15 years of filings, most recently posting 6.93% for Q1 2026.

• In Q1 2026, EBT Margin fell 552.0% year-over-year to 6.93%; the TTM figure through Mar 2026 stood at 9.51% (up 320.0% YoY), while the FY2025 annual figure was 10.79%, up 419.0% from the prior year.
• EBT Margin slipped to 6.93% in Q1 2026, from 16.05% in the prior quarter.
• Over the last five years, EBT Margin for ABBV reached as high as 36.41% in Q1 2022 and fell as low as 15.02% in Q4 2024.
• The 5-year median for EBT Margin is 14.02% (2023), against an average of 12.8%.
• Annual changes were most pronounced in 2023 — EBT Margin tumbled 3252 bps — and 2025, when it soared 3108 bps.
• A 5-year view of EBT Margin shows it stood at 19.61% in 2022, then plunged by 57 bps to 8.47% in 2023, then slumped by 277 bps to 15.02% in 2024, then surged by 207 bps to 16.05% in 2025, then tumbled by 57 bps to 6.93% in 2026.
• According to Business Quant data, EBT Margin over the past three periods registered 6.93%, 16.05%, and 4.53% for Q1 2026, Q4 2025, and Q3 2025 respectively.